Evaluation of Covid 19 Anxiety in Endometriosis Patients

Completed

• Conditions: Covid19; Endometriosis

• Registration Number: NCT04337346
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

It is aimed to measure the general anxiety and lifestyle information of endometriosis patients about covid 19 pandemic, to evaluate anxiety levels in this period.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-05
• Study First Submitted: 2020-04-05
• Study First Submitted QC: 2020-04-06
• Study First Posted: 2020-04-07
• Primary Completion: 2020-04-20
• Study Completion: 2020-04-25
• Status Verified: 2020-05
• Last Update Submitted: 2020-05-18
• Last Update Posted: 2020-05-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• endometriosis patients
• no psychiatric illness
• no antidepressant use

Read More

Exclusion Criteria

• women who had not endometriosis
• no extra health conditions
• women younger than 18 and older than 45

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Covid 19 Anxiety levels in Endometriosis Patients	20 days	The Beck Anxiety Inventory (BAI); it measures the frequency of anxiety symptoms experienced by the patient. It consists of 21 questions in total. Each item gets an increasing score between 0-3. The total score ranges from 0 - 63. The following guidelines are recommended for the interpretation of scores: 0 -9, normal or no anxiety; 10 -18, mild to moderate anxiety; 19 -29, moderate to severe anxiety; and 30 - 63, severe anxiety.

Trial Locations

Locations (1)

Pinar Yalcin Bahat; 🇹🇷 Istanbul, İ̇stanbul, Turkey